Dual bronchodilation and exacerbations of COPD
- PMID: 27746982
- PMCID: PMC5059243
- DOI: 10.21037/jtd.2016.08.92
Dual bronchodilation and exacerbations of COPD
Conflict of interest statement
The authors have no conflicts of interest to declare.
Comment on
-
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15. N Engl J Med. 2016. PMID: 27181606 Clinical Trial.
References
-
- Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease. Available online: http://goldcopd.org/ - PubMed
-
- Wedzicha JA, Decramer M, Ficker JH, et al. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. Lancet Respir Med 2013;1:199-209. 10.1016/S2213-2600(13)70052-3 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources